Compare HUMAW & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HUMAW | PNTG |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | United States |
| Employees | 220 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 1.0B |
| IPO Year | N/A | N/A |
| Metric | HUMAW | PNTG |
|---|---|---|
| Price | $0.11 | $28.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $35.33 |
| AVG Volume (30 Days) | 14.2K | ★ 242.1K |
| Earning Date | 03-21-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 10.47 |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $847,274,000.00 |
| Revenue This Year | N/A | $36.42 |
| Revenue Next Year | N/A | $23.99 |
| P/E Ratio | ★ N/A | $38.64 |
| Revenue Growth | N/A | ★ 29.89 |
| 52 Week Low | $1.18 | $21.18 |
| 52 Week High | $1.34 | $30.46 |
| Indicator | HUMAW | PNTG |
|---|---|---|
| Relative Strength Index (RSI) | 36.37 | 53.86 |
| Support Level | $0.08 | $28.99 |
| Resistance Level | $0.13 | $29.91 |
| Average True Range (ATR) | 0.03 | 0.66 |
| MACD | -0.00 | -0.20 |
| Stochastic Oscillator | 4.14 | 13.57 |
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.